JP Morgan Chase’s MiMedx Group MDXG Stock Holding History

JP Morgan Chase’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-112,500	Closed	-$695K	–	5822
2018 Q3	$695K	Sell	112,500 -10,000	-8%	-$45.2K	﹤0.01%	4118
2018 Q2	$783K	Buy	122,500 +32,500	+36%	+$231K	﹤0.01%	3955
2018 Q1	$627K	Buy	90,000 +27,000	+43%	+$314K	﹤0.01%	3914
2017 Q4	$794K	Buy	+63,000	New	+$768K	﹤0.01%	3851
2017 Q2	–	Sell	-152,300	Closed	-$1.45M	–	5106
2017 Q1	$1.45M	Buy	152,300 +141,900	+1,364%	+$1.2M	﹤0.01%	3223
2016 Q4	$92K	Buy	+10,400	New	+$93.4K	﹤0.01%	4420
2015 Q2	–	Sell	-550,000	Closed	-$5.72M	–	4111
2015 Q1	$5.72M	Buy	550,000 +50,000	+10%	+$468K	﹤0.01%	2253
2014 Q4	$5.76M	Buy	+500,000	New	+$4.94M	﹤0.01%	2318

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

JP Morgan Chase's MDXG Position: Q2 2026 in Review

JP Morgan Chase increased its MiMedx Group (MDXG) stake by 169% in Q2 2026, buying an estimated $300K and bringing the position to 131,049 shares worth $512K. The position accounts for ﹤0.01% of the portfolio, ranked #5104.

JP Morgan Chase first reported a position in MDXG in Q2 2013 and has held it in 42 quarters since. The position peaked at $21M in Q3 2014. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

JP Morgan Chase held 131,049 shares of MiMedx Group worth $512K as of Q2 2026.
JP Morgan Chase bought 82,271 MiMedx Group shares in Q2 2026, an estimated $300K.
MiMedx Group made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5104 holding.
JP Morgan Chase first reported a position in MiMedx Group in Q2 2013 and has held it in 42 quarters since.
JP Morgan Chase's MiMedx Group position peaked at $21M in Q3 2014.
227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.